1. Bishop J, Huether CA, Torfs C, Lorey F, Deddens J. Epidemiologic study of Down syndrome in a racially diverse California population, 1989-1991. Am J Epidemiol 1997;145:134-47.

2. Antonarakis SE. Parental origin of the extra chromosome in trisomy 21 as indicated by analysis of DNA polymorphisms. Down Syndrome Collaborative Group. N Engl J Med 1991;324:872-6.

3. Carlesimo GA, Marotta L, Vicari S. Long-term memory in mental retardation: evidence for a specific impairment in subjects with Down's syndrome. Neuropsychologia 1997;35:71-9.

4. Wang PP, Bellugi U. Evidence from two genetic syndromes for a dissociation between verbal and visual-spatial short-term memory. J Clin Exp Neuropsychol 1994;16:317-22.

5. Jarrold C, Baddeley AD, Hewes AK. Genetically dissociated components of working memory: evidence from Down's and Williams syndrome. Neuropsychologia 1999;37:637-51.

6. Silverstein AB, Legutki G, Friedman SL, Takayama DL. Performance of Down syndrome individuals on the Stanford-Binet Intelligence Scale. Am J Ment Defic 1982;86:548-51.

7. Capone GT. Down syndrome: advances in molecular biology and the neurosciences. J Dev Behav Pediatr 2001;22:40-59.

8. Schmidt-Sidor B, Wisniewski KE, Shepard TH, Sersen EA. Brain growth in Down syndrome subjects 15 to 22 weeks of gestational age and birth to 60 months. Clin Neuropathol 1990;9:181-90.

9. Aylward EH, Habbak R, Warren AC, et al. Cerebellar volume in adults with Down syndrome. Arch Neurol 1997; 54:209-12.

10. Jernigan TL, Bellugi U, Sowell E, Doherty S, Hesselink JR. Cerebral morphologic distinctions between Williams and Down syndromes. Arch Neurol 1993;50:186-91.

11. Becker L, Mito T, Takashima S, Onodera K. Growth and development of the brain in Down syndrome. Prog Clin Biol Res 1991;373:133-52.

12. Wisniewski KE. Down syndrome children often have brain with maturation delay, retardation of growth, and cortical dysgenesis. Am J Med Genet Suppl 1990;7:274-81.

13. Pinter JD, Eliez S, Schmitt JE, Capone JD, Reiss AL. Neuroanatomy of Down syndrome: a high-resolution MRI study. Am J Psychiatry 2001;158:1659-65.

14. Aylward EH, Li Q, Habbak QR, et al. Basal ganglia volume in adults with Down syndrome. Psychiatry Res 1997;74:73-82.

15. Mann DM, Yates PO, Marcyniuk B. Some morphometric observations on the cerebral cortex and hippocampus in presenile Alzheimer's disease, senile dementia of Alzheimer type and Down's syndrome in middle age. J Neurol Sci 1985;69:139-59.

16. Glenner GG, Wong CW. Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein. Biochem Biophys Res Commun 1984;122:1131-5.

17. Wisniewski KE, Wisniewski HM, Wen GY. Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome. Ann Neurol 1985;17:278-82.

18. Teller JK, Russo C, DeBusk LM, et al. Presence of soluble amyloid beta-pep-tide precedes amyloid plaque formation in Down's syndrome. Nat Med 1996;2:93-5.

19. Korenberg JR, Chen XN, Hirota H, et al. VI. Genome structure and cognitive map of Williams syndrome. J Cogn Neurosci 2000;12:89-107.

20. Morris CA, Demsey SA, Leonard CO, Dilts C, Blackburn BL. Natural history of Williams syndrome: physical characteristics. J Pediatr 1988;113:318-26.

21. Kaplan P, Wang PP, Francke U. Williams (Williams Beuren) syndrome: a distinct neurobehavioral disorder. J Child Neurol 2001;16:177-90.

22. Bellugi U, Lichtenberger L, Jones W, Lai Z, St George M. I. The neurocognitive profile of Williams Syndrome: a complex pattern of strengths and weaknesses. J Cogn Neurosci 2000;12:7-29.

23. Einfeld SL, Tonge BJ, Rees VW. Longitudinal course of behavioral and emotional problems in Williams syndrome. Am J Ment Retard 2001;106:73-81.

24. Galaburda AM, Bellugi U. V. Multi-level analysis of cortical neuroanatomy in Williams syndrome. J Cogn Neurosci 2000;12:74-88.

25. Reiss AL, Eliez S, Schmitt JE, et al. IV. Neuroanatomy of Williams syndrome: a high-resolution MRI study. J Cogn Neurosci 2000;12:65-73.

26. Jernigan TL, Bellugi U. Anomalous brain morphology on magnetic resonance images in Williams syndrome and Down syndrome. Arch Neurol 1990; 47:529-33.

27. Wang PP, Hesselink JR, Jernigan TL, Doherty S, Bellugi U. Specific neurobehavioral profile of Williams' syndrome is associated with neocerebel-lar hemispheric preservation. Neurology 1992;42:1999-2002.

28. Schmahmann JD, Sherman JC. Cerebellar cognitive affective syndrome. Int Rev Neurobiol 1997;41:433-40.

29. Schmahmann JD. An emerging concept. The cerebellar contribution to higher function. Arch Neurol 1991;48:1178-87.

30. Galaburda AM, Wang PP, Bellugi U, Rossen M. Cytoarchitectonic anomalies in a genetically based disorder: Williams syndrome. NeuroReport 1994;5:753-7.

31. Schmitt JE, Eliez S, Bellugi U, Reiss AL. Analysis of cerebral shape in Williams syndrome. Arch Neurol 2001;58:283-7.

32. Schmitt JE, Watts K, Eliez S, Galaburda AM, Bellugi U, Reiss AL. Increased gyrification: evidence using 3D MRI methods in Williams syndrome. Dev Med Child Neurol 2002;44:292-5.

33. Galaburda AM, Schmitt JE, Bellugi U, Eliez S, Reiss AL. Dorsal forebrain anomaly in Williams syndrome. Arch Neurol 2001;58:1865-9.

34. Botta A, Sangiuolo F, Calza L, et al. Expression analysis and protein localization of the human HPC- 1/syntaxin 1A, a gene deleted in Williams syndrome. Genomics 1999;62:525-8.

35. Arber S, Barbayannis FA, Hanser H, et al. Regulation of actin dynamics through phosphorylation of cofilin by LIM-kinase. Nature 1998;393:805-9.

36. Yang N, Higuchi O, Ohashi K, et al. Cofilin phosphorylation by LIM-kinase 1 and its role in Rac-mediated actin reorganization. Nature 1998;393:809-12.

37. Frangiskakis JM, Ewart AK, Morris CA, et al. LIM-kinase1 hemizygosity implicated in impaired visuospatial constructive cognition. Cell 1996;86: 59-69.

38. Wang YK, Samos CH, Peoples R, Perez-Jurado LA, Nusse R, Francke U. A novel human homologue of the Drosophila frizzled wnt receptor gene binds wingless protein and is in the Williams syndrome deletion at 7q11.23. Hum Mol Genet 1997;6:465-72.

39. Cadigan KM, Nusse R. Wnt signaling: a common theme in animal development. Genes Dev 1997;11:3286-305.

40. Kooy RF, Oostra BA, Willems PJ. The fragile X syndrome and other fragile site disorders. Results Probl Cell Differ 1998;21:1-46.

41. Hagerman RJ, Cronister A. Fragile X syndrome: diagnosis, treatment, and research. Baltimore: Johns Hopkins University Press, 1996.

42. Cohen IL, Fisch GS, Sudhalter V, et al. Social gaze, social avoidance, and repetitive behavior in fragile X males: a controlled study. Am J Ment Retard 1988;92:436-46.

43. Kemper MB, Hagerman RJ, Altshul-Stark D. Cognitive profiles of boys with the fragile X syndrome. Am J Med Genet 1988;30:191-200.

44. Sudhalter V, Cohen IL, Silverman W, Wolf-Schein EG. Conversational analyses of males with fragile X, Down syndrome, and autism: comparison of the emergence of deviant language. Am J Ment Retard 1990;94:431-41.

45. Reiss AL, Freund L. Behavioral phenotype of fragile X syndrome: DSM-III-R autistic behavior in male children. Am J Med Genet 1992;43:35-46.

46. Miezejeski CM, Jenkins EC, Hill AL, Wisniewski K, French JH, Brown WT. A profile of cognitive deficit in females from fragile X families. Neuropsychologia 1986;24:405-9.

47. Reiss AL, Freund L, Abrams MT, Boehm C, Kazazian H. Neurobehavioral effects of the fragile X premutation in adult women: a controlled study. Am J Hum Genet 1993;52:884-94.

48. Freund LS, Reiss AL, Abrams MT. Psychiatric disorders associated with fragile X in the young female. Pediatrics 1993;91:321-9.

49. Prouty LA, Rogers RC, Stevenson RE, et al. Fragile X syndrome: growth, development, and intellectual function. Am J Med Genet 1988;30:123-42.

50. Oberle I, Rousseau F, Heitz D, et al. Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome. Science 1991; 252:1097-102.

51. Tamanini F, Bontekoe C, Bakker CE, et al. Different targets for the fragile X-related proteins revealed by their distinct nuclear localizations. Hum Mol Genet 1999;8:863-9.

52. Sabaratnam M. Pathological and neuropathological findings in two males with fragile-X syndrome. J Intell Disab Res 2000;44:81-5.

53. Abitbol M, Menini C, Delezoide AL, Rhyner T, Vekemans M, Mallet J. Nucleus basalis magnocellularis and hippocampus are the major sites of FMR-1 expression in the human fetal brain. Nat Genet 1993;4:147-53.

54. Devys D, Lutz Y, Rouyer N, Bellocq JP, Mandel JL. The FMR-1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation. Nat Genet 1993;4:335-40.

55. Irwin SA, Galvez R, Greenough WT. Dendritic spine structural anomalies in fragile-X mental retardation syndrome. Cereb Cortex 2000;10:1038-44.

56. Irwin SA, Patel B, Idupulapati M, et al. Abnormal dendritic spine characteristics in the temporal and visual cortices of patients with fragile-X syndrome: a quantitative examination. Am J Med Genet 2001;98:161-7.

57. Rudelli RD, Brown WT, Wisniewski K, et al. Adult fragile X syndrome. Clinico-neuropathologic findings. Acta Neuropathol 1985;67:289-95.

58. Wisniewski KE, Segan SM, Miezejeski CM, Sersen EA, Rudelli RD. The Fra(X) syndrome: neurological, electrophysiological, and neuropathological abnormalities. Am J Med Genet 1991;38:476-80.

59. Schenck A, Bardoni B, Moro A, Bagni C, Mandel JL. A highly conserved protein family interacting with the fragile X mental retardation protein (FMRP) and displaying selective interactions with FMRP-related proteins FXR1P and FXR2P. Proc Natl Acad Sci USA 2001;3:3.

60. Hall A. Rho GTPases and the actin cytoskeleton. Science 1998;279:509-14.

61. Fischer M, Kaech S, Knutti D, Matus A. Rapid actin-based plasticity in dendritic spines. Neuron 1998;20:847-54.

62. Reiss AL, Lee J, Freund L. Neuroanatomy of fragile X syndrome: the temporal lobe. Neurology 1994;44:1317-24.

63. Kates WR, Abrams MT, Kaufmann WE, Breiter SN, Reiss AL. Reliability and validity of MRI measurement of the amygdala and hippocampus in children with fragile X syndrome. Psychiatry Res 1997;75:31-48.

64. Reiss AL, Aylward E, Freund LS, Joshi PK, Bryan RN. Neuroanatomy of fragile X syndrome: the posterior fossa. Ann Neurol 1991;29:26-32.

65. Reiss AL, Freund L, Tseng JE, Joshi PK. Neuroanatomy in fragile X females: the posterior fossa. Am J Hum Genet 1991;49:279-388.

66. Mostofsky SH, Mazzocco MM, Aakalu G, Warsofsky IS, Denckla MB, Reiss AL. Decreased cerebellar posterior vermis size in fragile X syndrome: correlation with neurocognitive performance. Neurology 1998;50:121-30.

67. Reiss AL, Abrams MT, Greenlaw R, Freund L, Denckla MB. Neuro-developmental effects of the FMR-1 full mutation in humans. Nat Med 1995;1:159-67.

68. Kwon H, Menon V, Eliez S, et al. Functional neuroanatomy of visuospatial working memory in fragile x syndrome: relation to behavioral and molecular measures. Am J Psychiatry 2001;158:1040-51.

69. Menon V, Kwon H, Eliez S, Taylor AK, Reiss AL. Functional brain activation during cognition is related to FMR1 gene expression. Brain Res 2000;877:367-70.

70. Mazzocco MM. Advances in research on the fragile X syndrome. Ment Retard Dev Disab Res Rev 2000;6:96-106.

71. Ashley CT, Sutcliffe JS, Kunst CB, et al. Human and murine FMR-1: alternative splicing and translational initiation downstream of the CGG-repeat. Nat Genet 1993;4:244-51.

72. Consortium D-BFX. Fmr1 knockout mice: a model to study fragile X mental retardation. The Dutch-Belgian Fragile X Consortium. Cell 1994;78:23-33.

73. Kooy RF, D'Hooge R, Reyniers E, et al. Transgenic mouse model for the fragile X syndrome. Am J Med Genet 1996;64:241-5.

74. D'Hooge R, Nagels G, Franck F, et al. Mildly impaired water maze performance in male Fmr1 knockout mice. Neuroscience 1997;76:367-76.

75. Chen L, Toth M. Fragile X mice develop sensory hyperreactivity to auditory stimuli. Neuroscience 2001;103:1043-50.

76. Musumeci SA, Bosco P, Calabrese G, et al. Audiogenic seizures susceptibility in transgenic mice with fragile X syndrome. Epilepsia 2000;41:19-23.

77. Miller LJ, Mcintosh DN, McGrath J, et al. Electrodermal responses to sensory stimuli in individuals with fragile X syndrome: a preliminary report. Am J Med Genet 1999;83:268-79.

78. Comery TA, Harris JB, Willems PJ, et al. Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits. Proc Natl Acad Sci USA 1997;94:5401-4.

79. Irwin SA, Idupulapati M, Mehta AB, et al. Abnormal dendritic and dendritic spine characteristics in fragile-X patients and the mouse model of fragile-X syndrome. Soc Neurosci Abstr 1999;25:2548.

80. Godfraind JM, Reyniers E, De Boulle K, et al. Long-term potentiation in the hippocampus of fragile X knockout mice. Am J Med Genet 1996;64:246-51.

81. Paradee W, Melikian HE, Rasmussen DL, Kenneson A, Conn PJ, Warren ST. Fragile X mouse: strain effects of knockout phenotype and evidence suggesting deficient amygdala function. Neuroscience 1999;94:185-92.

82. Wu ZL, Thomas SA, Villacres EC, et al. Altered behavior and long-term potentiation in type I adenylyl cyclase mutant mice. Proc Natl Acad Sci USA 1995;92:220-4.

83. Sakimura K, Kutsuwada T, Ito I, et al. Reduced hippocampal LTP and spatial learning in mice lacking NMDA receptor epsilon 1 subunit. Nature 1995; 373:151-5.

84. Bakker CE, de Diego Otero Y, Bontekoe C, et al. Immunocytochemical and biochemical characterization of FMRP, FXR1P, and FXR2P in the mouse. Exp Cell Res 2000;258:162-70.

85. Peier AM, McIlwain KL, Kenneson A, Warren ST, Paylor R, Nelson DL. (Over)correction of FMR1 deficiency with YAC transgenics: behavioral and physical features. Hum Mol Genet 2000;9:1145-59.

86. Kooy RF, Reyniers E, Verhoye M, et al. Neuroanatomy of the fragile X knockout mouse brain studied using in vivo high resolution magnetic resonance imaging. Eur J Hum Genet 1999;7:526-32.

Unraveling Alzheimers Disease

Unraveling Alzheimers Disease

I leave absolutely nothing out! Everything that I learned about Alzheimer’s I share with you. This is the most comprehensive report on Alzheimer’s you will ever read. No stone is left unturned in this comprehensive report.

Get My Free Ebook

Post a comment